AFP and liver cancer: SAA is often significantly elevated in HCC patients and shows diagnostic value particularly in AFP-negative individuals, while CRP serves as both an inflammatory marker and a potential prognostic indicator in liver cancer.[7] Our findings further confirmed that the combination of these 3 biomarkers yielded improved sensitivity and specificity, consistent with prior studies.[14]